Maguate, Gresna .

HRN: 26-05-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2024
CEFTRIAXONE 1G (VIAL)
10/14/2024
10/21/2024
IV
2g
OD
CAP MR
Waiting Final Action 
10/14/2024
AZITHROMYCIN 500MG TABLET (TAB)
10/14/2024
10/19/2024
PO
500mg
OD
CAP MR
Waiting Final Action 
10/22/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/22/2024
10/28/2024
IV
1.5g
Q6h
CAP MR
Waiting Final Action 
10/22/2024
RIFAXIMIN 200MG (TAB)
10/22/2024
10/28/2024
PO
550mg
BID
Intra Abdominal Infection
Waiting Final Action 
10/24/2024
LEVOFLOXACIN 500MG (TAB)
10/24/2024
10/31/2024
PO
500mg
OD
CAP
Waiting Final Action 
10/26/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
10/26/2024
11/02/2024
IV
500mg
OD
Cap Mr
Waiting Final Action 
10/26/2024
CEFTRIAXONE 1G (VIAL)
10/26/2024
11/02/2024
IV
2g
OD
Cap Mr
Waiting Final Action 
10/26/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/26/2024
10/26/2024
IV
4.5gm
LD
Septicemia
Waiting Final Action 
10/26/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/26/2024
11/01/2024
IV
2.25gm
Q6
Septicemia; Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: